A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells

Cited 143 time in scopus
Metadata Downloads
A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells
H C Yoo; S J Park; M Nam; J Kang; K Kim; J H Yeo; J K Kim; Y Heo; H S Lee; Myeong Youl LeeChang Woo LeeJong Soon Kang; Y H Kim; J Lee; J Choi; G S Hwang; S Bang; J M Han
Bibliographic Citation
Cell Metabolism, vol. 31, pp. 267-283
Publication Year
Glutamine is an essential nutrient that regulates energy production, redox homeostasis, and signaling in cancer cells. Despite the importance of glutamine in mitochondrial metabolism, the mitochondrial glutamine transporter has long been unknown. Here, we show that the SLC1A5 variant plays a critical role in cancer metabolic reprogramming by transporting glutamine into mitochondria. The SLC1A5 variant has an N-terminal targeting signal for mitochondrial localization. Hypoxia-induced gene expression of the SLC1A5 variant is mediated by HIF-2α. Overexpression of the SLC1A5 variant mediates glutamine-induced ATP production and glutathione synthesis and confers gemcitabine resistance to pancreatic cancer cells. SLC1A5 variant knockdown and overexpression alter cancer cell and tumor growth, supporting an oncogenic role. This work demonstrates that the SLC1A5 variant is a mitochondrial glutamine transporter for cancer metabolic reprogramming.
ASCT2HIF-2αSLC1A5SLC1A5 variantcancer metabolismgemcitabine resistanceglutaminehypoxiametabolic reprogrammingmitochondrial glutamine transporter
Elsevier-Cell Press
Appears in Collections:
Ochang Branch Institute > Division of National Bio-Infrastructure > Laboratory Animal Resource & Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.

Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.